Literature DB >> 12468482

Leflunomide can potentiate the anticoagulant effect of warfarin.

V Lim1, I Pande.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12468482      PMCID: PMC137810          DOI: 10.1136/bmj.325.7376.1333

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

Review 1.  Clinical experience with leflunomide in rheumatoid arthritis. Leflunomide Investigators' Group.

Authors:  B Rozman
Journal:  J Rheumatol Suppl       Date:  1998-07

2.  Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study.

Authors:  V Mladenovic; Z Domljan; B Rozman; I Jajic; D Mihajlovic; J Dordevic; M Popovic; M Dimitrijevic; M Zivkovic; G Campion
Journal:  Arthritis Rheum       Date:  1995-11
  2 in total
  6 in total

1.  Suppressed wound healing in a patient with rheumatoid arthritis taking leflunomide (arava).

Authors:  D Miller Wise
Journal:  Perm J       Date:  2011

2.  Genetic polymorphism of CYP1A2 and the toxicity of leflunomide treatment in rheumatoid arthritis patients.

Authors:  Petra Bohanec Grabar; Blaz Rozman; Matija Tomsic; Dasa Suput; Dusan Logar; Vita Dolzan
Journal:  Eur J Clin Pharmacol       Date:  2008-05-22       Impact factor: 2.953

Review 3.  Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing.

Authors:  Nicola Alcorn; Sarah Saunders; Rajan Madhok
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

4.  Perioperative management of medications used in the treatment of rheumatoid arthritis.

Authors:  Carla R Scanzello; Mark P Figgie; Bryan J Nestor; Susan M Goodman
Journal:  HSS J       Date:  2006-09

5.  The mysterious gross haematuria in patient on Leflunomide: A case report and literature review.

Authors:  Vincent Khor; Lie Kwok Ying
Journal:  Urol Case Rep       Date:  2018-10-20

6.  Role of oral teriflunomide in the management of multiple sclerosis.

Authors:  Radu Tanasescu; Nikos Evangelou; Cris S Constantinescu
Journal:  Neuropsychiatr Dis Treat       Date:  2013-04-22       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.